Onychomatricoma

From WikiMD's Medical Encyclopedia

Revision as of 04:33, 4 April 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


Onychomatricoma
Synonyms
Pronounce N/A
Specialty Dermatology
Symptoms Thickened nail, nail plate discoloration, splinter hemorrhages
Complications
Onset
Duration
Types N/A
Causes Unknown
Risks
Diagnosis Clinical examination, dermoscopy, histopathology
Differential diagnosis Onychomycosis, glomus tumor, subungual exostosis
Prevention N/A
Treatment Surgical excision
Medication
Prognosis Excellent with complete excision
Frequency Rare
Deaths N/A


Onychomatricoma is a rare benign tumor of the nail matrix that was first described in 1992 by Baran and Kint. It is characterized by a slow-growing, painless, thickened nail plate with splinter hemorrhages and xanthonychia. The tumor is often misdiagnosed due to its rarity and lack of awareness among clinicians.

Clinical Presentation[edit]

Patients with onychomatricoma typically present with a slow-growing, thickened nail plate that may be associated with pain. The nail plate often shows longitudinal ridging and splitting, with splinter hemorrhages and xanthonychia. The nail may also be deformed or partially destroyed.

Diagnosis[edit]

The diagnosis of onychomatricoma is often challenging due to its rarity and the lack of specific clinical features. The diagnosis is usually confirmed by histopathology following a nail biopsy. Histologically, the tumor is characterized by the presence of fibroepithelial papillae and a thickened nail matrix.

Treatment[edit]

The treatment of choice for onychomatricoma is complete surgical excision of the tumor. This usually results in a cure, although recurrence has been reported in some cases.

Prognosis[edit]

The prognosis for patients with onychomatricoma is generally good, as the tumor is benign and does not metastasize. However, the tumor can cause significant morbidity due to its effects on the nail and the potential for recurrence.

See Also[edit]

References[edit]

  • Baran R, Kint A. Onychomatricoma. J Am Acad Dermatol. 1992;26(2 Pt 1):247-250.
  • Perrin C, Baran R, Pisani A, et al. The onychomatricoma: additional histologic criteria and immunohistochemical study. Am J Dermatopathol. 2002;24(3):199-203.
This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?

Get started with evidence based, physician-supervised

affordable GLP-1 weight loss injections

Now available in New York City and Philadelphia:

✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends

Learn more:

Start your transformation today with W8MD weight loss centers.

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.